Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2021

01-02-2021 | Pancreaticojejunostomy | Pancreatic Tumors

The Landmark Series: Mitigation of the Postoperative Pancreatic Fistula

Authors: George Van Buren II, MD, Charles M. Vollmer Jr., MD

Published in: Annals of Surgical Oncology | Issue 2/2021

Login to get access

Abstract

Pancreatic fistula has been the defining complication and challenge of pancreatic surgery. Better awareness and mitigation of postoperative pancreatic fistulas has led to significant improvements in morbidity and mortality of pancreatic surgery. The definition and management of pancreatic fistulas has sequentially progressed over the last three decades; the literature ranges from retrospective, observational studies to prospective multicenter randomized controlled trials. The landmark literature contributions driving the perioperative management of pancreatic fistulas are detailed in this article.
Literature
1.
McMillan MT, Vollmer CM. Predictive factors for pancreatic fistula following pancreatectomy. Langenbecks Arch Surg. 2014;399(7): 811–24.PubMedCrossRef
2.
Vining CC, Kristine K, Darryl S, Pierce P, Yaniv B, Kevin KR, et al. Risk factors for complications in patients undergoing pancreaticoduodenectomy: a NSQIP analysis with propensity score matching. J Surg Oncol. 2020;122(2):183–94.PubMedCrossRef
3.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1): 8–13.PubMedCrossRef
4.
Enestvedt CK, Diggs BS, Cassera MA, Hammill C, Hansen PD, Wolf RF. Complications nearly double the cost of care after pancreaticoduodenectomy. Am J Surg.. 2012;204(3): 332–8.PubMedCrossRef
5.
Pratt WB, Maithel SK, Vanounou T, Huang ZS, Callery MP, Vollmer Jr CM. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) classification scheme. Ann Surg. 2007. 245(3):443–51.PubMedPubMedCentralCrossRef
6.
Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer Jr CM. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1): 1–14.PubMedCrossRef
7.
Pratt WB, Callery MP, Vollmer CM. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg. 2008;32(3): 419–28.PubMedCrossRef
8.
Bassi C, Marchegiani G, Dervenis C, Sarr M, Hilal MA, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3): 584–91.PubMedCrossRef
9.
Pratt W, Maithel SK, Vanounou T, Callery MP, Vollmer CM. Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy. J Gastrointest Surg. 2006;10(9):1264–78 (discussion 1278–9).PubMedCrossRef
10.
Harnoss JC, Ulrich AB, Harnoss JM, Diener MK, Büchler MW, Welsch T. Use and results of consensus definitions in pancreatic surgery: a systematic review. Surgery. 2014;155(1): 47–57.PubMedCrossRef
11.
McMillan MT, Christein JD, Callery MP, Behrman SW, Drebin JA, Hollis RH, et al. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. Surgery. 2016;159(4):1013–22.PubMedCrossRef
12.
Rosso E, Casnedi S, Pessaux P, Oussoultzoglou E, Panaro F, Mahfud M, et al. The role of “fatty pancreas” and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg. 2009;13(10):1845–51.PubMedCrossRef
13.
Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246(6):1058–64PubMedCrossRef
14.
Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, et al. A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy. J Gastrointest Surg. 2014;18(1): 172–79 (discussion 179–80)PubMedCrossRef
15.
Trudeau MT, Casciani F, Ecker BL, Maggino L, Seykora TF, Puri P, et al. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy. Ann Surg. 2020.
16.
Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, et al. Characterization and optimal management of high-risk pancreatic anastomoses during pancreatoduodenectomy. Ann Surg. 2018;267(4): 608–16.PubMedCrossRef
17.
Al Abbas AI, Borrebach JD, Pitt HA, Bellon J, Hogg ME, Zeh HJ, et al. Development of a novel pancreatoduodenectomy-specific risk calculator: an analysis of 10,000 patients. J Gastrointest Surg. 2020;15:1–9
18.
Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995;222(4): 580–8 (discussion 588-92).
19.
Cheng Y, Briarava M, Lai M, Wang X, Tu B, Cheng N, et al. Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy. Cochrane Database Syst Rev. 2017;9:CD012257.
20.
Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, et al. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg. 2009;208(5): 738–47; discussion 747-9.
21.
Bai X, Zhang Q, Gao S, Lou J, Li G, Zhang Y, et al. Duct-to-mucosa vs invagination for pancreaticojejunostomy after pancreaticoduodenectomy: a prospective, randomized controlled trial from a single surgeon. J Am Coll Surg. 2016;222(1):10–8.PubMedCrossRef
22.
Ball CG, Pitt HA, Kilbane ME, Dixon E, Sutherland FR, Lillemoe KD. Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB (Oxford). 2010;12(7):465–71.PubMedPubMedCentralCrossRef
23.
De Castro SM, Busch OR, Van Gulik TM, Obertop H, Gouma DJ. Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg. 2005;92(9):1117–23.PubMedCrossRef
24.
Seykora TF, Ecker BL, McMillan MT, Maggino L, Beane JD, Fong ZV, et al. The Beneficial effects of minimizing blood loss in pancreatoduodenectomy. Ann Surg. 2019;270(1):147–57.PubMedCrossRef
25.
McMillan MT, Vollmer CM, Asbun HJ, Ball CG, Bassi C, Beane JD, et al. The characterization and prediction of ISGPF grade C fistulas following pancreatoduodenectomy. J Gastrointest Surg. 2016;20(2): 262–76.PubMedCrossRef
26.
McMillan MT, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, et al. Incorporation of procedure-specific risk into the ACS-NSQIP Surgical Risk Calculator Improves the prediction of morbidity and mortality after pancreatoduodenectomy. Ann Surg. 2017;265(5): 978–86.PubMedCrossRef
27.
Heslin MJ, Harrison LE, Brooks AD, Hochwald SN, Coit DG, Brennan MF. Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg. 1998;2(4):373–8.PubMedCrossRef
28.
Conlon KC, Labow D, Leung D, Smith A, Jarnagin W, Coit DG, et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg. 2001;234(4):487–93; discussion 493-4.
29.
Van Buren, G., Bloomston M, Hughes SJ, Winter J, Behrman SW, Zyromski NJ, Vollmer C, et al. A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg. 2014;259(4):605–12.PubMedCrossRef
30.
Witzigmann H, Diener MK, Kienkötter S, Rossion I, Bruckner T, Werner B, et al. No need for routine drainage after pancreatic head resection: the dual-center, randomized, controlled PANDRA trial (ISRCTN04937707). Ann Surg. 2016;264(3): 528–37.PubMedCrossRef
31.
Zhang W, He S, Cheng Y, Xia J, Lai M, Cheng N, et al. Prophylactic abdominal drainage for pancreatic surgery. Cochrane Database Syst Rev. 2018;6:CD010583PubMed
32.
Bassi C, Molinari E, Malleo G, Crippa S, Butturini G, Salvia R, et al. Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg. 2010;252(2):207–14.PubMedCrossRef
33.
Molinari E, Bassi C, Salvia R, Butturini G, Crippa S, Talamini G, et al. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg. 2007;246(2): 281–7.PubMedPubMedCentralCrossRef
34.
Trudeau MT, Maggino L, Chen B, McMillan MT, Lee MK, Roses R, et al. Extended experience with a dynamic, data-driven selective drain management protocol in pancreaticoduodenectomy: progressive risk stratification for better practice. J Am Coll Surg. 2020;230(5): 809–18.e1.CrossRef
35.
Williams ST, Woltering EA, O’Dorisio TM, Fletcher WS. Effect of octreotide acetate on pancreatic exocrine function. Am J Surg. 1989;157(5): 459–62.PubMedCrossRef
36.
Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery. 1995;117(1): 26—31.PubMedCrossRef
37.
Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232(3):419–29.PubMedPubMedCentralCrossRef
38.
Koti RS, Gurusamy KS, Fusai G, Davidson BR. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a cochrane review. HPB (Oxford). 2010;12(3): 155–65.PubMedPubMedCentralCrossRef
39.
McMillan MT, Christein JD, Callery MP, Behrman SW, Drebin JA, Kent TS, et al. Prophylactic octreotide for pancreatoduodenectomy: more harm than good? HPB (Oxford). 2014;16(10): 954–62.PubMedPubMedCentralCrossRef
40.
Allen PJ, Gönen M, Brennan MF, Bucknor AA, Robinson LM, Pappas MM, et al. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014;371(9): 875–6.PubMedCrossRef
41.
McMillan MT, Malleo G, Bassi C, Sprys MH, Vollmer Jr CM. Defining the practice of pancreatoduodenectomy around the world. HPB (Oxford). 2015; 17(12):1145–54.PubMedPubMedCentralCrossRef
42.
Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD. et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2006; 10(9):1280–90 (discussion 1290).PubMedCrossRef
43.
Smyrniotis V, Arkadopoulos N, Kyriazi MA, Derpapas M, Theodosopoulos T, Gennatas C, et al. Does internal stenting of the pancreaticojejunostomy improve outcomes after pancreatoduodenectomy? a prospective study. Langenbecks Arch Surg. 2010;395(3): 195–200.PubMedCrossRef
44.
Sachs TE, Pratt WB, Kent TS, Callery MP, Vollmer Jr CM. The pancreaticojejunal anastomotic stent: friend or foe? Surgery. 2013;153(5):651–62.PubMedCrossRef
45.
Poon RT, Fan ST, Lo CM, Ng KK, Yuen WK, Yeung C, et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007;246(3): 425–33 (discussion 433–5).PubMedPubMedCentralCrossRef
46.
Pessaux P, Sauvanet A, Mariette C, Paye F, Muscari F, Cunha AS, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg. 2011;253(5):879–85.PubMedCrossRef
47.
McMillan MT, Ecker BL, Behrman SW, Callery MP, Christein JD, Drebin JA, et al. Externalized stents for pancreatoduodenectomy provide value only in high-risk scenarios. J Gastrointest Surg. 2016;20(12): 2052–62.PubMedCrossRef
48.
Weber SM, Cho CS, Merchant N, Pinchot S, Rettammel R, Nakeeb A, et al. Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol. 2009;16(10):2825–33.PubMedCrossRef
49.
Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beckman RM, et al. Risk factors and mitigation strategies for pancreatic fistula after distal pancreatectomy: analysis of 2026 resections from the international, multi-institutional distal pancreatectomy study group. Ann Surg. 2019;269(1):143–49.PubMedCrossRef
50.
Diener MK, Knaebel HP, Witte ST, Rossion I, Kieser M, Buchler MW, et al. DISPACT trial: a randomized controlled trial to compare two different surgical techniques of DIStal PAnCreaTectomy—study rationale and design. Clin Trials. 2008;5(5):534–45.PubMedCrossRef
51.
Kawai M, Hirono S, Okada KI, Sho M, Nakajima Y, Eguchi H, et al. Randomized controlled trial of pancreaticojejunostomy versus stapler closure of the pancreatic stump during distal pancreatectomy to reduce pancreatic fistula. Ann Surg. 2016;264(1):180–7.PubMedCrossRef
52.
Van Buren, G, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, et al. A prospective randomized multicenter trial of distal pancreatectomy with and without routine intraperitoneal drainage. Ann Surg. 2017;266(3):421–31.PubMedCrossRef
53.
Kaiser J, Niesen W, Probst P, Bruckner T, Doerr-Harim C, Strobel O. et al. Abdominal drainage versus no drainage after distal pancreatectomy: study protocol for a randomized controlled trial. Trials. 2019;20(1): 332.PubMedPubMedCentralCrossRef
54.
Seykora TF, Liu JB, Maggino L, Pitt HA, Vollmer Jr CM. Drain management following distal pancreatectomy: characterization of contemporary practice and impact of early removal. Ann Surg;2019.
Metadata
Title
The Landmark Series: Mitigation of the Postoperative Pancreatic Fistula
Authors
George Van Buren II, MD
Charles M. Vollmer Jr., MD
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09251-6

Other articles of this Issue 2/2021

Annals of Surgical Oncology 2/2021 Go to the issue

Pancreatic Tumors

The Landmark Series: Pancreatic Neuroendocrine Tumors

Health Services Research and Global Oncology

2020 SSO Presidential Address: Surgical Oncology Moonshot

Gastrointestinal Oncology

Validation Study of Fibrinogen and Albumin Score in Esophageal Cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort Study

Breast Oncology

Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study

Translational Research

Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas

Hepatobiliary Tumors

Tumor Necrosis in Hepatocellular Carcinoma—Unfairly Overlooked?